Parkwood LLC Forma Therapeutics Holdings, Inc. Transaction History

Parkwood LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $304,868 - $536,992	-36,555 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $98,056 - $179,456	7,210 Added 24.57%	36,555 $520,000
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $89,484 - $108,376	4,217 Added 16.78%	29,345 $681,000
Q2 2021 Aug 13, 2021	BUY	$22.86 - $30.95 $23,934 - $32,404	1,047 Added 4.35%	25,128 $625,000
Q1 2021 May 14, 2021	SELL	$24.58 - $42.82 $494,475 - $861,409	-20,117 Reduced 45.52%	24,081 $675,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $1.54 Million - $2.26 Million	44,198 New	44,198 $1.54 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.